e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Modified exhaled nitric oxide measurement in monocrotaline-exposed rats to monitor pulmonary hypertension
M. S. Strobl, C. Schreiber, S. Hubmer, H. Bergmeister, I. M. Lang, D. Bonderman (Austria)
Source:
Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Session:
Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Session type:
Thematic Poster Session
Number:
3902
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. S. Strobl, C. Schreiber, S. Hubmer, H. Bergmeister, I. M. Lang, D. Bonderman (Austria). Modified exhaled nitric oxide measurement in monocrotaline-exposed rats to monitor pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 3902
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Fractional exhaled nitric oxide in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Exhaled nitric oxide levels in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 584s
Year: 2003
Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 55s
Year: 2007
Endothelin system, exhaled nitric oxide and high altitude pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 551s
Year: 2007
Exhaled nitric oxide and pulmonary function tests in children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 759s
Year: 2007
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
Source: Eur Respir J 2003; 21: 433-438
Year: 2003
An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004
Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model
Source: Eur Respir J 2006; 28: 1236-1244
Year: 2006
Infused nitric oxide in experimental pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 348s
Year: 2007
Measurement of exhaled nitric oxide in children
Source: Guideline 2002
Year: 2002
Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Diagnosing asthma using exhaled nitric oxide (eNO) measurements
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003
Effect of caffeine on exhaled nitric oxide measurements in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003
Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Pulmonary function test and fraction of exhaled nitric oxide of asthma in remission
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Nitric oxide metabolite flux during exercise in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Exhaled nitric oxide measurement in the diagnosis and management of pulmonary tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Increased eNO and pulmonary iNOS expression in eNOS null mice
Source: Eur Respir J 2003; 21: 770-773
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept